Author information:
(1)From the NMR Research Unit (R.C., L.M., C.T., F.D., M.C.Y., F.P., F.B., 
O.C.), Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, 
UCL Institute of Neurology, University College London; NMO Clinical Service at 
the Walton Centre (K.A.-A., A.J.), Liverpool; Translational Imaging Group (F.P., 
S.O., F.B.), Centre for Medical Image Computing (CMIC), Department of Medical 
Physics and Bioengineering, University College London; Lysholm Department of 
Neuroradiology (T.A.Y.), National Hospital for Neurology and Neurosurgery, 
London, UK; Department of Radiology and Nuclear Medicine (F.B.), MS Centre 
Amsterdam, VU Medical Centre Amsterdam, the Netherlands; and National Institute 
for Health Research (NIHR) (T.A.Y., F.B., O.C.), University College London 
Hospitals (UCLH) Biomedical Research Centre, London, UK. r.cortese@ucl.ac.uk.
(2)From the NMR Research Unit (R.C., L.M., C.T., F.D., M.C.Y., F.P., F.B., 
O.C.), Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, 
UCL Institute of Neurology, University College London; NMO Clinical Service at 
the Walton Centre (K.A.-A., A.J.), Liverpool; Translational Imaging Group (F.P., 
S.O., F.B.), Centre for Medical Image Computing (CMIC), Department of Medical 
Physics and Bioengineering, University College London; Lysholm Department of 
Neuroradiology (T.A.Y.), National Hospital for Neurology and Neurosurgery, 
London, UK; Department of Radiology and Nuclear Medicine (F.B.), MS Centre 
Amsterdam, VU Medical Centre Amsterdam, the Netherlands; and National Institute 
for Health Research (NIHR) (T.A.Y., F.B., O.C.), University College London 
Hospitals (UCLH) Biomedical Research Centre, London, UK.